It is time to cross the bridge from pleural space to plasma, with more research, larger cohorts, and longitudinal studies about the relevance of plasmatic ADA as a biomarker of TB disease and pattern recognition as an alternative method of diagnosing sputum negative PTB. This evidence concerns the gene ADA and tuberculosis.